Ceftizoxime: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 16: | Line 16: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[ | ''' [[Ceftizoxime description|Description]]''' | ||
'''| [[ | '''| [[Ceftizoxime clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Ceftizoxime microbiology|Microbiology]]''' | ||
'''| [[ | '''| [[Ceftizoxime indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Ceftizoxime contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Ceftizoxime warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Ceftizoxime adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Ceftizoxime overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[Ceftizoxime clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[Ceftizoxime dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Ceftizoxime compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | ||
'''| [[ | '''| [[Ceftizoxime directions for use|Directions For Use]]''' | ||
'''| [[ | '''| [[Ceftizoxime how supplied|How Supplied]]''' | ||
'''| [[ | '''| [[Ceftizoxime labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== |
Revision as of 04:24, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ceftizoxime is a third-generation cephalosporin available for parenteral administration.
Unlike other 3rd generation cephalosporins, in ceftizoxime the whole C-3 side chain has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subjected to metabolism.
Category
Cephalosporin, Third-Generation
US Brand Names
CEFIZOX®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages